Noninvasive Risk Stratification of Patients With Transthyretin Amyloidosis | Zendy

Arnt V. Kristen | Zendy; Katrin Scherer | Zendy; Sebastian J. Buss | Zendy; Fabian aus dem Siepen | Zendy; Sabine Haufe | Zendy; Ralf Bauer | Zendy; Katrin Hinderhofer | Zendy; Evangelos Giannitsis | Zendy; Stefan E. Hardt | Zendy; Uwe Haberkorn | Zendy; Hugo A. Katus | Zendy; Henning Steen | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Noninvasive Risk Stratification of Patients With Transthyretin Amyloidosis

Author(s) -

Arnt V. Kristen,

Katrin Scherer,

Sebastian J. Buss,

Fabian aus dem Siepen,

Sabine Haufe,

Ralf Bauer,

Katrin Hinderhofer,

Evangelos Giannitsis,

Stefan E. Hardt,

Uwe Haberkorn,

Hugo A. Katus,

Henning Steen

Publication year - 2014

Publication title -

jacc. cardiovascular imaging

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.79

H-Index - 120

eISSN - 1936-878X

pISSN - 1876-7591

DOI - 10.1016/j.jcmg.2014.03.002

Subject(s) - cardiac amyloidosis , medicine , cardiology , scintigraphy , receiver operating characteristic , heart failure , left ventricular hypertrophy , magnetic resonance imaging , amyloidosis , cardiomyopathy , radiology , blood pressure

We sought to evaluate noninvasive parameters by electrocardiography, echocardiography, technetium-99m-3,3-diphosphono-1,2-propanodicarboxylic acid ((99m)Tc-DPD) scintigraphy, and cardiac magnetic resonance for the prediction of all-cause mortality in patients with cardiac transthyretin amyloidosis (ATTR).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research